Home31R • FRA
Revive Therapeutics Ltd
€0.015
Mar 28, 9:16:26 AM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityCA headquartered
Previous close
€0.015
Day range
€0.015 - €0.015
Year range
€0.0054 - €0.064
Market cap
8.72M CAD
Avg Volume
3.61K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD)Dec 2023Y/Y change
Revenue
Operating expense
784.33K-48.85%
Net income
-770.62K49.47%
Net profit margin
Earnings per share
EBITDA
-784.25K48.85%
Effective tax rate
Total assets
Total liabilities
(CAD)Dec 2023Y/Y change
Cash and short-term investments
708.42K-0.25%
Total assets
12.88M-6.99%
Total liabilities
3.35M-22.75%
Total equity
9.53M
Shares outstanding
358.45M
Price to book
0.51
Return on assets
-14.71%
Return on capital
-19.47%
Net change in cash
(CAD)Dec 2023Y/Y change
Net income
-770.62K49.47%
Cash from operations
-883.42K-0.81%
Cash from investing
Cash from financing
0.00
Net change in cash
-883.42K-0.81%
Free cash flow
-612.49K-89.40%
About
Founded
2012
Employees
2
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu